VRAX
Virax Biolabs Group Limited Ordinary Shares
NASDAQ: VRAX · HEALTHCARE · BIOTECHNOLOGY
$0.13
-0.81% today
Updated 2026-04-30
Market cap
$993260.00
P/E ratio
—
P/S ratio
332.64x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$0 – $1
Volume
15.9M
Virax Biolabs Group Limited Ordinary Shares (VRAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | $22609.00 | $94118.00 | $48706.00 | $9.81M | $5.48M | $6.43M |
| Cash & equivalents | $22609.00 | $17621.00 | $21756.00 | $9.35M | $3.59M | $4.23M |
| Current assets | $22609.00 | $39621.00 | $48706.00 | $9.63M | $4.38M | $4.89M |
| Total liabilities | $1.24M | $871435.00 | $1.25M | $908401.00 | $345194.00 | $964750.00 |
| Current liabilities | $1.24M | $871435.00 | $1.25M | $908401.00 | $168849.00 | $673207.00 |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-1.06M | $-596185.00 | $-974578.00 | $9.13M | $5.37M | $5.70M |
| Retained earnings | $-3.98M | $-4.63M | $-6.34M | $-11.79M | $-18.53M | $-24.59M |
| Accounts receivable | $0.00 | $928.00 | $0.00 | $-24095.00 | $217843.00 | $30654.00 |
| Inventory | $0.00 | $21072.00 | $20951.00 | $24095.00 | $60383.00 | $94675.00 |
| Goodwill | — | — | — | — | — | — |